Back to Search
JOHN BEARY, M.D.
M.D.
Rheumatology Physician
NPI: 1619901055IndividualAccepts Medicare
Specialties, Licenses & Credentials
Clinical Pharmacology Physician
Clinical Pharmacology
Code: 208U00000X
35073642(OH)
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
35073642(OH)
CMS Specialties
PrimaryRHEUMATOLOGY
Education
HARVARD MEDICAL SCHOOL
Class of 1973
Research & Publications (13)
Joint structure modification in osteoarthritis: development of SMOAD drugs.
PMID 11709113·Curr Rheumatol Rep·2001
6-review
Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: a phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study.
PMID 19302900·Clin Ther·2009
3-trial
Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period.
PMID 17728333·Ann Rheum Dis·2008
8-other
Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.
PMID 17993283·Osteoarthritis Cartilage·2008
4-observational
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis.
PMID 17920005·Bone·2008
2-rct
Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study.
PMID 17672891·Arthritis Res Ther·2007
8-other
Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study.
PMID 17958901·Arthritis Res Ther·2007
4-observational
Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.
PMID 17075851·Arthritis Rheum·2006
3-trial
Food and Drug Administration centennial: recognizing the guardians of our drug supply.
PMID 17009312·Arthritis Rheum·2006
8-other
Comparison of fixed flexion, fluoroscopic semi-flexed and MTP radiographic methods for obtaining the minimum medial joint space width of the knee in longitudinal osteoarthritis trials.
PMID 16684612·Osteoarthritis Cartilage·2006
4-observational
Prevalence of exposure to Salmonella spp in finishing swine marketed in Iowa.
PMID 16649917·Am J Vet Res·2006
7-preclinical
Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes.
PMID 16507119·Arthritis Res Ther·2006
8-other
Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173].
PMID 15899049·Arthritis Res Ther·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3200 VINE ST
CINCINNATI, OH 45220 - Phone
- (513) 861-3100
Quick Facts
- NPI
- 1619901055
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 53
- Publications
- 13
Are you this provider?
Claim Your Profile